• Allogeneic Stem Cell Transplant With Graft Versus Host Disease In France In 2012 Based On National Hospital Databases (Pmsi)

    Nov 1, 2014, 00:00

  • Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As)

    Nov 1, 2014, 00:00

  • The Development of an Integrated Ecoa Solution To Improve The Quality of Data Capture In Diabetes Clinical Trials

    Nov 1, 2014, 00:00

  • Preliminary Steps in the Development of an Algorithm for Identifying Relapsed CLL Patients in Secondary Data

    Nov 1, 2014, 00:00

  • Impact of Story Books on Promoting Knowledge and Behavior of 4th Stage Elementary Students About Rational Use of Medicines in Kermanshah Provine of Iran 2008

    Nov 1, 2014, 00:00

  • Economic Evaluation on Hepatitis B Vaccination Strategies for Preventing Mother-To-Child Transmission in China

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Analysis of Bacillus Calmette-Guérin (BCG) Immunotherapy for Bladder Cancer

    Nov 1, 2014, 00:00

  • Burden of Renal Impairment- Relative Health Care Resource use in Prostate Cancer Patients with Bone Metastases

    Nov 1, 2014, 00:00

  • Comparison of Diagnostic Strategies to Detect Prevalent Vertebral Fracture for Adults Over Age 50- Use of Vertebral Fracture Assessment or Spine Radiography

    Nov 1, 2014, 00:00

  • How To Improve Health Outcomes In the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2014, 00:00

  • Prevention and Management of Medicine Shortages in Belgium, France and from The Perspective of the European Union

    Nov 1, 2014, 00:00

  • Burden of Prostate Cancer and Future Need for Health Care Services

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Apixaban Compared To Warfarin And Aspirin In Patients With Non-Valvular Atrial Fibrillation (Nvaf) In The Russian Federation

    Nov 1, 2014, 00:00

  • Predictors of Functional Disability in Patients With Chronic Lumbosacral Radicular Pain

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Methodological Evaluation Of The Impact Of Survival Costs In Oncology Modelling

    Nov 1, 2014, 00:00

  • Long-Term Costs and Consequences of Patients with Familial Chylomicronemia Syndrome – A Simulation Model Approach

    Nov 1, 2014, 00:00

  • Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC)- A Retrospective Claims Analysis

    Nov 1, 2014, 00:00

  • Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines Application

    Nov 1, 2014, 00:00

  • Media Coverage of the Nice First Draft Consultation Guidance for Trastuzumab Emantansine (Kadcyla) In Breast Cancer

    Nov 1, 2014, 00:00

  • Systematic Review Of Mathematical Models Predicting Relative Effectiveness

    Nov 1, 2014, 00:00

  • Economic Impact of Dengue Episode- Multicenter Study Across Four Brazilian Regions

    Nov 1, 2014, 00:00

  • Cost Effectiveness Evaluation of Canagliflozin In Combination With Metformin in the Treatment Of Type 2 Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Characteristics of Patients with Pleural Mesothelioma in the Russian Federation

    Nov 1, 2014, 00:00

  • Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in Slovenia

    Nov 1, 2014, 00:00

  • The Prevalence of Hypoglycemia and Its Impact on The Quality of Life of Type 2 Diabetes Mellitus Patients in Greece (The Hypo Study)

    Nov 1, 2014, 00:00

  • National Health Insurance Fund Drug Expenditure in Bulgaria, 2007-2012- Reference Based Pricing Alone or in Combination With Other Approaches to Pricing

    Nov 1, 2014, 00:00

  • A Comprehensive Assessment of Early Trial Evidence in Primary Breast Cancer- How Decisions Change Over Time

    Nov 1, 2014, 00:00

  • Patient-Reported Medical Expenditures For Insulin-Treated Diabetes Patients In Eastern, Central And Western Regions Of China

    Nov 1, 2014, 00:00

  • The Greek Health Care Reform After Troika's Involvement- The Potential Impact on Global Pricing and Access Strategy

    Nov 1, 2014, 00:00

  • Treatments Prior to and Post Percutaneous Coronary Intervention (PCI) in China

    Nov 1, 2014, 00:00

  • Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

    Nov 1, 2014, 00:00

  • The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Canagliflozin Verse Insulin-Secretagogues (Sulphonylureas) or Insulin In Patients With Type 2 Diabetes Mellitus (T2dm) As An Add-On To Metformin In Ireland

    Nov 1, 2014, 00:00

  • Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy- Real-Life Practice Data Using CPRD

    Nov 1, 2014, 00:00

  • Long-Term Outcomes of Ledipasvir/Sofosbuvir (LDV/ SOF) for the Treatment of Chronic Hepatitis C Infected (HCV) Genotype 1 Patients in the UK

    Nov 1, 2014, 00:00

  • Health Technology Assessments for Personalised Medicines- Are Current Methodologies Suitable for the Assessment of Personalised Therapies?

    Nov 1, 2014, 00:00

  • Nub Status - A 2014 Situation Analysis for Drugs- Oncology As Leading Therapeutic Area

    Nov 1, 2014, 00:00

  • Recruiting Cardiologists and Chronic Heart Patients From A Managed Physician Panel To Support Clinical Studies Phase Iii/Iv Or Health Outcome Studies

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Norway

    Nov 1, 2014, 00:00

  • The Impact of Influenza like Illness (ILI) in Children on Working Adults

    Nov 1, 2014, 00:00

  • Burden Associated with Agitation in Schizophrenia

    Nov 1, 2014, 00:00

  • Atomoxetine for the Treatment of Newly Diagnosed Adults with Adhd - a Cost Effectiveness Analysis in Spain

    Nov 1, 2014, 00:00

  • The Relationship Between Masked Hypertension and Obesity

    Nov 1, 2014, 00:00

  • Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management- Spanish Scenario

    Nov 1, 2014, 00:00

  • Cost-Analysis of Chronic Idiopathic Urticaria Disease

    Nov 1, 2014, 00:00

  • The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies

    Nov 1, 2014, 00:00

  • The Impact of Different Levels of Clinical Pharmacist Interventions on the Therapeutic Plan and Cost Saving

    Nov 1, 2014, 00:00

  • Real World Evidence in Mainland China- Experience with the Use of Health Care Claims Data

    Nov 1, 2014, 00:00

  • Anti-Tnf Biosimilars Indicated for Rheumatoid Arthritis are Increasingly Available in Europe- How Do Payers and Key Stakeholders Perceive Them?

    Nov 1, 2014, 00:00

  • Economic Comparison of Empirical Versus Diagonstic-Driven Strategies for Immunocompromised Patients with Suspected Fungal Infection Results from a Chinese Payer Perspective

    Nov 1, 2014, 00:00

  • Estimating The Value Of Cangrelor From Eliminating Preloading In Coronary Artery Bypass Graft (Cabg) Patients

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Oxycodone Lp An Opioid Analgesic for Patients With Moderate To Severe Pain Secondary To Cancer In Mexico

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin In The Treatment of Type 2 Diabetes Mellitus In Slovakia

    Nov 1, 2014, 00:00

  • Cost-Benefit Model of Varying Nexplanon and Other Long-Acting Reversible Contraceptive (Larc) Methods- Uptake Compared to the Oral Contraceptive Pill- UK Perspective

    Nov 1, 2014, 00:00

  • Costs Associated with the Use of Enzyme-Inducing Anti-Epileptic Drugs Versus Non-Enzyme-Inducing Anti-Epileptic Drugs- A Systematic Review

    Nov 1, 2014, 00:00

  • Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in Sweden

    Nov 1, 2014, 00:00

  • Deterministic Versus Stochastic Prediction of Risk for Cardiovascular Events

    Nov 1, 2014, 00:00

  • Impact Of International And Therapeutic Referencing On Prices And Launch Optimization

    Nov 1, 2014, 00:00

  • The Costs of Major and Minor Cycling Accidents in Tasmania, Australia

    Nov 1, 2014, 00:00

  • The Quality of Search Methodology and Search Reporting in Published Systematic Reviews of Economic Evaluations- Search Sources

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluation of Health Technologies Developed In Brazil From 1980-2013

    Nov 1, 2014, 00:00

  • Efficacy and Hospitalization Length of Stay of Single Dose Oritavancin Compared to 7-10 Days of Vancomycin in Patients with Acute Bacterial Skin and Skin Structure Infections in the Us and Eastern Europe

    Nov 1, 2014, 00:00

  • An Efficient Design for Cost-Effectiveness Studies of Personalized Medicine Strategies

    Nov 1, 2014, 00:00

  • Comparing How Single Arm Phase II Trial Data Can Support Approval of Oncologics by European Health Technology Assessment Bodies

    Nov 1, 2014, 00:00

  • The Cost Of Illness Of Atrial Fibrillation In Italy- A Cohort Of Hospitalized Patients

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Saxagliptin When Added To Metformin And Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus In Spain

    Nov 1, 2014, 00:00

  • Burden of Non-Adherence To Type 1 Diabetes Mellitus Therapeutic Guidelines In France

    Nov 1, 2014, 00:00

  • Impact of Cigarette and Alcohol Use on Adverse Drug Reactions of Haart Therapy Among HIV/AIDS Patients

    Nov 1, 2014, 00:00

  • Does Blood Lipid Screening is Cost-Effectiveness Among Chinese Adults Aged 45 And Above?

    Nov 1, 2014, 00:00

  • The Impact Of Pharmaceutical Policies On Pharmaceutical Sales Patterns In Sweden And Japan

    Nov 1, 2014, 00:00

  • Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders

    Nov 1, 2014, 00:00

  • Drug Utilization Pattern of Lisdexamfetamine Dimesylate in Germany

    Nov 1, 2014, 00:00

  • Predicted Versus Actual Budget Impact of High-Cost Drugs In Ireland

    Nov 1, 2014, 00:00

  • The Randomized Blind Start Trial- Evaluation of A New Study Design for Assessing Clinical Outcomes in Rare and Heterogeneous Patient Populations

    Nov 1, 2014, 00:00

  • Price Variation in Obstetrical Services in A Rural State

    Nov 1, 2014, 00:00

  • Does A 12-Lead Ecg More Reliably Detect Atrial Fibrilation Than A Rhythm Strip Only Ecg?

    Nov 1, 2014, 00:00

  • The Importance of Treatment Classifications that Account for Concomitant Treatments in the Context of a Network Meta-Analysis Comparing Pharmacological Treatments for Chronic Heart Failure

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey

    Nov 1, 2014, 00:00

  • Oncology Products in the Amnog Process – Learnings for a Successful Dossier Submission

    Nov 1, 2014, 00:00

  • An Assessment of the Association Between Rural Status and Health Service Resource Use Among Patients With Ankle Sprains in Ontario

    Nov 1, 2014, 00:00

  • Comparison of Generic, Condition-Specific and Mapped Health State Utility Values for Pediatric Asthma

    Nov 1, 2014, 00:00

  • Ivacaftor for Patients with Cystic Fibrosis- Clinical Efficacy and Cost-Effectiveness

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Sweden

    Nov 1, 2014, 00:00

  • Time Savings With Transtuzumab Subcutaneous (SC) Injection Verse Trastuzumab Intravenous (IV) Infusion- A Time and Motion Study in 3 Russian Centers

    Nov 1, 2014, 00:00

  • Exploring the Usefulness of Social Media and Patient Forums in Identifying indirect Costs of a Disease

    Nov 1, 2014, 00:00

  • The Case For Early Payer Engagement

    Nov 1, 2014, 00:00

  • Economic Impact of the Inclusion of Pertuzumab for the Treatment of Metastatic Breast Cancer HER2 +

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Canagliflozin Verse Liraglutide In Patients With Type 2 Diabetes (T2dm) Failing To Achieve Glycaemic Control On Metformin Monotherapy In Ireland

    Nov 1, 2014, 00:00

  • Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany

    Nov 1, 2014, 00:00

  • Early Nice Decision Problem Meetings- Implications For Cross-Functional Industry Teams

    Nov 1, 2014, 00:00

  • Goal Attainment Scaling – A Useful Individualized Clinical Outcome Measure

    Nov 1, 2014, 00:00

  • Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison

    Nov 1, 2014, 00:00

  • Drug Utilization Study of Antipsychotics used for the Hospital Treatment Of Schizophrenia in Russia

    Nov 1, 2014, 00:00

  • Whole Exome Sequencing as a Diagnostic Tool for Complex Neurological Disorders

    Nov 1, 2014, 00:00

  • The Burden of Parkinson Disease Amongst Caregivers in Spain Over 4 Years

    Nov 1, 2014, 00:00

  • Quantification of Switching Trends in the Greek Pharmaceutical Market During the Period Of Crisis

    Nov 1, 2014, 00:00

  • HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW

    Nov 1, 2014, 00:00

  • Place Of Residence And Employment Status After Stroke

    Nov 1, 2014, 00:00

  • Cardiovascular Risk, Gender And Medication Adherence In Rural Area Of Vietnam

    Nov 1, 2014, 00:00

  • Cost Analysis of two Aftercare Strategies in Chronic Continuous Intrathecal Baclofen Therapy in Patients with Intractable Spasticity

    Nov 1, 2014, 00:00

  • All-Cause Mortality Validation of the Core Diabetes Model Against Predictions of the Charlson Comorbidity Index

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Use of an Infant Formula Based on Partially Hydrolyzed Serum Protein as Compared With a Standard Whole Cow's Milk Formula for Prevention of Atopic Dermatitis in Children Under 3 Years Old

    Nov 1, 2014, 00:00

  • Tadalafil in Benign Prostatic Hyperplasia- Protocol for the Systematic Review of Adverse Events

    Nov 1, 2014, 00:00

  • Primary Pacemaker Insertion- Gender Differences In Prior Er Utilization

    Nov 1, 2014, 00:00

  • Factors Conditioning Health Related Quality Of Life In Patients With Psoriasis In Europe- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Budget Impact Of The Introduction Of New Oral Anticoagulants (Noac) For No Valve Atrial Fibrillation (Nvaf) In Extremadura

    Nov 1, 2014, 00:00

  • Different Strategies for Latent TB Assessment in Patients Undergoing Anti-TNF Treatment- an Economic Model

    Nov 1, 2014, 00:00

  • Budget Impact Model of Sunitinib as First Line Treatment of Metastatic Renal Cell Carcinoma in China

    Nov 1, 2014, 00:00

  • Exploring Uncertainty in Economic Evaluation Of Medicines- A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has)

    Nov 1, 2014, 00:00

  • Comparing the Equivalence of Eq-5d-5l Across Different Modes of Administration

    Nov 1, 2014, 00:00

  • Alzheimer's Disease Caregiver Burden in Japan and the 5 E.U

    Nov 1, 2014, 00:00

  • An Analysis Of Determinants Of New And Bland-Name Drugs Prescription Behavior Among Japanese Physicians

    Nov 1, 2014, 00:00

  • The Effects of Gallium Chloride on Apoptosis Osteoporosis Model of Rats Caused by Tretinoin Acid

    Nov 1, 2014, 00:00

  • Patients With COPD who Initiate Roflumilast in Sweden

    Nov 1, 2014, 00:00

  • Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe- Optimising Market Access in Increasingly Challenging Markets

    Nov 1, 2014, 00:00

  • Determination of Cost-Effectiveness Threshold For Malaysia

    Nov 1, 2014, 00:00

  • Assessment of Need, Development and Implementation of Supportive Management Database for the Treatment of Poisoning Cases in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Burden of Disease Analysis of Psoriatic Arthritis In Hungary

    Nov 1, 2014, 00:00

  • Incidence-Based Cost of Asthma in Vietnam

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Everolimus for the Treatment of Hormone Receptor Positive, Human Epidermal Growth Factor Receptor-2 Negative (HER2-) Advanced Breast Cancer in Kazakhstan

    Nov 1, 2014, 00:00

  • Treatment Patterns Among Type 2 Diabetes Mellitus Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia- Results from the National Cross-Sectional Study

    Nov 1, 2014, 00:00

  • Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response- European North American Comparative Efficacy) Study

    Nov 1, 2014, 00:00

  • An Electronic Version of the Pdq-39- Acceptability To Respondents and Assessment of Alternative Response formats

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Raltegravir in Hiv-Infected Treatment Naive Patients in Greece

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Evaluating Factor Viii As Primary Prophylaxis Treatment for Patients With Severe Haemophilia A In the Netherlands

    Nov 1, 2014, 00:00

  • Impact of Hypoglycemia on Discontinuing or Down-Titrating Sulfonylurea Among Type 2 Diabetes Patients Without Insulin

    Nov 1, 2014, 00:00

  • Comparative Pharmacoeconomic Analysis of the Application of Posaconazole, Fluconazole and Itraconazole With the Purpose of Primary Prevention of Invasive Fungal Infection In Patients With Neutropenia During Chemotherapy for Acute Myelogenou ...

    Nov 1, 2014, 00:00

  • Impact of Hospital Volume on Breast Cancer Outcome- A Population Based Study in the Netherlands

    Nov 1, 2014, 00:00

  • Understanding The Role of Subgroup Analysis And Tests For Homogeneity or Interaction in the Amnog Dossier

    Nov 1, 2014, 00:00

  • The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening

    Nov 1, 2014, 00:00

  • The Risk of Metabolic Disorders in Patients Treated with Asenapine or Olanzapine- A Real World Data Study Conducted in Italy and Spain

    Nov 1, 2014, 00:00

  • Evaluation Of The Economic Impact Of Specialist Outpatient Clinic Pharmacy Interventions In A Tertiary Institution, Singapore

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Surgical Management of Stress Urinary Incontinence With Single-Incision Mini-Sling Versus Tension-Free Vaginal Obturator in Spain

    Nov 1, 2014, 00:00

  • Alzheimer's Disease- Medication Costs and Impact of Generic Substitution

    Nov 1, 2014, 00:00

  • Economic Impact of Clinical Researches to the Research Centers and Reimbursement Systems in Turkey

    Nov 1, 2014, 00:00

  • Macular Oedema Due to Retinal Vein Occlusion Methods for the Identification of Treatment Guidelines and Areas of Unmet Clinical Needs by Means of Systematic Review

    Nov 1, 2014, 00:00

  • Adoption of Oral Disease Modifying Treatments to Manage Patients with Relapsing Remitting Multiple Sclerosis from 2011-2013 in the United States

    Nov 1, 2014, 00:00

  • A Network Meta-Analysis Comparing the Efficacy And Safety of Ceftobiprole and Selected Comparators in the Treatment of Hospital-Acquired Pneumonia

    Nov 1, 2014, 00:00

  • Population Access to Rotavirus Vaccination in Industrialized Countries- Lessons Learnt from Current Experience

    Nov 1, 2014, 00:00

  • The Impact Of The New Drug Co-Payment Scheme On Economic Evaluations In Spain

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Lung Cancer in the Slovak Republic

    Nov 1, 2014, 00:00

  • Do the Us Panel Recommendations Hold for Europe? Investigating the Relation Between Quality of Life Versus Work-Status, Absenteeism and Presenteeism

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Endobronchial Valve Therapy for Severe Emphysema- A Model-Based Projection Based on the Vent Study

    Nov 1, 2014, 00:00

  • Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation- Reflection On A General Modeling Framework And Key Methodological Points

    Nov 1, 2014, 00:00

  • Physicians' and Patients' Preferences Over the Attributes of Biological Agents Used In the Treatment of Rheumatic Diseases In Spain- A Conjoint Analysis

    Nov 1, 2014, 00:00

  • Health Status in Adult Patients with Copd in Korea

    Nov 1, 2014, 00:00

  • Impact of Pulmonary Exacerbations On Eq-5d Measures In Patients With Cystic Fibrosis

    Nov 1, 2014, 00:00

  • Quality Of Hospital Food And Its Safety Assessment

    Nov 1, 2014, 00:00

  • Review Of Reference Pricing Effects On Pharmaceuticals

    Nov 1, 2014, 00:00

  • Cost Of Diabetes Related Chronic Complication In South Korea 2011

    Nov 1, 2014, 00:00

  • Prostate Cancer Overall Survival- Multilevel Analysis of A Population-Based Cancer Registry Data

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Czech Republic

    Nov 1, 2014, 00:00

  • Treating Verse Non-Treating Obsturictive Sleep Apnea in Italy and Fran A Markov Model-Based Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • A Study To Assess Disease Progression To Esrd Within A Year In Patients With Advanced Ckd

    Nov 1, 2014, 00:00

  • Common Illnesses Identified by Community Health Workers in the Households and Referrred to Primary Health Facilities For Care

    Nov 1, 2014, 00:00

  • The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients

    Nov 1, 2014, 00:00

  • Feasibility of Conducting Retrospective Studies Using Hashtags and Social Media Data From Facebook and Twitter

    Nov 1, 2014, 00:00

  • Impact of Maternal Education on Child Immunization Propensity in China

    Nov 1, 2014, 00:00

  • Influenza Vaccination in China Among the Urban Population and High-Risk Groups

    Nov 1, 2014, 00:00

  • Managing Congenital and Pediatric Cardiac Surgery Data Base- The Impact on Clincial Practice and Quality of Care

    Nov 1, 2014, 00:00

  • Awareness of Breast Cancer and its Prevention. A Comparative Survey Among Finnish and Hungarian Women

    Nov 1, 2014, 00:00

  • A Comparison of The Reliability and Validity of the Four-Item and Six-Item NISCI Symptom Summary Scores

    Nov 1, 2014, 00:00

  • An Evidence-Based Model Design to Inform the Cost-Effectiveness Evaluation of Primary Endocrine Therapy And Surgery for Older Women with Primary Breast Cancer

    Nov 1, 2014, 00:00

  • Trend in Prevalence and Distribution of Diabetes Mellitus Type I and Type II in the Netherlands

    Nov 1, 2014, 00:00

  • Impact of Allergen Immunotherapy on Quality of Life and Health Care Costs in Adults and Children With Grass Pollen-Induced Allergic Rhinitis in Germany

    Nov 1, 2014, 00:00

  • Association of Diabetes and Cancer Diagnosis in Primary Care Practices in France

    Nov 1, 2014, 00:00

  • Prescribing Patterns and Treatment Outcomes in North Indian Female Patients with Chronic Low Back Pain

    Nov 1, 2014, 00:00

  • New Meta-Analysis of Patient-Level Data on Efficacy And Hypoglycaemia with Insulin Glargine or Nph Insulin in Type 2 Diabetes Mellitus (T2DM) According to Concomitant Oral Therapy

    Nov 1, 2014, 00:00

  • Mapping European Database Usage- An Analysis of Published Data Types

    Nov 1, 2014, 00:00

  • Correlation Between End-of-Life Status of A Treatment And Likelihood of A Patient Access Scheme in The Setting of A Nice Review in The UK

    Nov 1, 2014, 00:00

  • Clinical Research for the Effectiveness and Economic Value of Qinxitong in the Patients with Ra in China

    Nov 1, 2014, 00:00

  • Non-Treatment Specific Parameter Value Estimates- Relationship Between BMI and Utility

    Nov 1, 2014, 00:00

  • Mast (Minimal Access Spinal Technologies) Versus Open Surgery- Cost Analysis From Hospital Perspective

    Nov 1, 2014, 00:00

  • Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections- Proof Of Concept in the United Arab Emirates

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of 1-Year Adjuvant Trastuzumab Therapy of Early-Stage Her2-Positive Breast Cancer

    Nov 1, 2014, 00:00

  • Reimbursed Pharmacotherapy of Metastatic Clear Cell Kidney Cancer (MCCKC) in the Czech Republic

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Biologic Therapies in Russian Patients With Rheumatoid Arthritis and Intolerance or Inadequate Response to Conventional Basic Therap

    Nov 1, 2014, 00:00

  • An Epidemiologic Modeling Application To Pharmacoeconomics for Improved Health Care Planning

    Nov 1, 2014, 00:00

  • Economic Evaluation of Catheter-Based Renal Denervation for Patients with Resistant Hypertension in Korea

    Nov 1, 2014, 00:00

  • Predictive Modelling for Optimal Target Population and Real-World Study Design- An Example In Mother-To-Child Transmission of HIV

    Nov 1, 2014, 00:00

  • The Burden of Primary Generalized Tonic-Clonic Seizures in Europe and the United States- An Analysis of The National Health and Wellness Survey

    Nov 1, 2014, 00:00

  • Obtaining Indirect Utilities with the Sf-6d and the Porpus-U in Prostate Cancer Patients

    Nov 1, 2014, 00:00

  • Patients' Preferences for Bone Metastases Treatments in Turkey

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Canagliflozin Compared With Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sulfonylurea In France

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Valsartan Versus Olmesartan Addition To Amlodipine And Hydrochlorothiaziade Single-Pill Triple Antihypertensive Therapy

    Nov 1, 2014, 00:00

  • Study of Antibiotic Prescription Pattern and Antibiotic Sesitivity in Surgery Patient in Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Acceptance Of Telemonitoring By Health Care Professionals in Germany- A Question Of Financial Conditions

    Nov 1, 2014, 00:00

  • What Relapsed/Refractory Cll/Mcl Treatment Outcomes Do German Patients And Physicians Find Most Important? Results from Qualitative Interviews

    Nov 1, 2014, 00:00

  • Predictions for Medical Subsidy Enrollment Among Young Children From High-Risk Families in Taipei

    Nov 1, 2014, 00:00

  • Immature Survival Data From Early Trial Termination – Theory and Hta Practice

    Nov 1, 2014, 00:00

  • Social Aspects of HCV Treatment In Kazakhstan

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Tolvaptan for the Treatment of Hyponatraemia Secondary To Syndrome Of Inappropriate Antidiuretic Hormone Secretion in Sweden

    Nov 1, 2014, 00:00

  • Local Variation in Primary Care Prescribing Behavior in England- Ticagrelor

    Nov 1, 2014, 00:00

  • Pharmaceutical Market Access in Russia- A Regional Maze?

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation and Burden of Illness of Acute Exacerbation of Copd in Patients in Malaysia

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of U100 Insulin In Egyptian Diabetic Patients

    Nov 1, 2014, 00:00

  • The Use and Acceptance of Novel Statistical Analyses To Support Technology Submissions To Hta Authorities

    Nov 1, 2014, 00:00

  • Cohort Of Hcv Patients In Italy- Sizing And Treatments In A Sample Of Italian Hepatology Centers

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Strontium Ranelate Verse Alendronate for Management of Osteoporosis Among Post-Menopausal Women in Malaysia Using A Markov Modelling Approach

    Nov 1, 2014, 00:00

  • Glycemic, Lipid, and Blood Pressure Control Among Individuals with Type 2 Diabetes Mellitus in Saudi Arabia

    Nov 1, 2014, 00:00

  • The Direct Cost of Asthma in Turkey

    Nov 1, 2014, 00:00

  • The Comparison Of Clinical Impact Between Entecavir And Tenofovir In Chronic Hbv Infection

    Nov 1, 2014, 00:00

  • A Spanish Cost-Effectiveness Analysis Of Sevelamer Versus Calcium Carbonate In Nondialysis-Dependent Chronic Kidney Disease (Ckd) Patients

    Nov 1, 2014, 00:00

  • Community Pharmacists Attitude and Perceived Need Towards the Provision of Pharmaceutical Care Services- A Qualitative Approach

    Nov 1, 2014, 00:00

  • Clinical Implementation of Genomic Sequencing in Pediatric Oncology- Identification and Valuation of Resources and Costs Associated with Next-Generation Sequencing

    Nov 1, 2014, 00:00

  • Monte-Carlo Simulation to Estimate the Health Care Costs Avoided With Fluticasone Furoate/Vilanterol Due to Exacerbation Rate Reduction in Spanish COPD Patients

    Nov 1, 2014, 00:00

  • Aging Impact Over the National Health Cost in Extremadura Public Health Expenditure of Extremadura in the Period 2011-21

    Nov 1, 2014, 00:00

  • Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria

    Nov 1, 2014, 00:00

  • Economic Evaluation Studies In Gastroenterology In Brazil- A Systematic Review

    Nov 1, 2014, 00:00

  • Current Status and Deficiency of Hemostasis in Surgery- A Systematic Literature Review, Including Chinese Literature

    Nov 1, 2014, 00:00

  • An Examination of the Regulatory and Reimbursement Processes for Biobetters and Comparison With Biosimilars

    Nov 1, 2014, 00:00

  • Type of Multimorbidity and Patient-Centered Care Among Elderly Medicare Beneficiaries

    Nov 1, 2014, 00:00

  • First-Line Therapy for Patients With Multiple Myeloma- Direct and Indirect Comparison of Treatment Regimens on the Existing Market

    Nov 1, 2014, 00:00

  • Mean Annual Cost Of Patients Hospitalized For Chronic Hepatitis C In Fran The Hepc-Lone Study

    Nov 1, 2014, 00:00

  • Examination of the Efficiency of Electrical Stimulation in Case of Stress and Urge Incontinence

    Nov 1, 2014, 00:00

  • Economic Evaluation of the Fixed Dose Combination of Indacaterol/ Glycopyrromium, as a Maintenance Bronchodilator Treatment in Adult Mexican Patients With COPD

    Nov 1, 2014, 00:00

  • Budgetary Implications of Introducing Fluticasone Furoate/Vilanterol for COPD in the UK

    Nov 1, 2014, 00:00

  • The Effect of Decentralised Public Health Care Provision on Accessibility To Medicines in Bosnia And Herzegovina

    Nov 1, 2014, 00:00

  • Example of Analysis Utilizing Real World Data- Medical Cost Reduction by Advising Untreated-Hypertension Patients to Visit Doctors

    Nov 1, 2014, 00:00

  • Fixed Dose Combinations of Nucleoside Reverse Transcriptase Inhibitor for Naïve Patient with Hiv Infection in Russia- Cost Comparison Analysis

    Nov 1, 2014, 00:00

  • Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology

    Nov 1, 2014, 00:00

  • The Budget Impact of Using Fidaxomicin for Hospitalised Cdi Patients from the Danish Health Care Perspective

    Nov 1, 2014, 00:00

  • An Archetype For Classification and Comparison of Hta Activities in Latin America

    Nov 1, 2014, 00:00

  • Medium Term Avoided Costs- High-Dose Hypoallergenic House Dust Mite Preparation Immunotherapy Verse Conventional Symptomatic Treatment

    Nov 1, 2014, 00:00

  • Research Prioritization In An Mcda Context- Existing Methods - New Results

    Nov 1, 2014, 00:00

  • Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study

    Nov 1, 2014, 00:00

  • Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism

    Nov 1, 2014, 00:00

  • Health Related Quality of Life and Patient Satisfaction in Colorectal Cancer Patients Treated Through Radical Surgery in Curative Intent in a Colo-Proctology Clinical Department

    Nov 1, 2014, 00:00

  • Single-ARM Studies to Support Drug Reimbursement in Australia

    Nov 1, 2014, 00:00

  • What Is The Proportion of Patients Who Return Counter Referral Slips to the Original Referral Service For Confirmation of Arrival to the Hospital?

    Nov 1, 2014, 00:00

  • Effects of A Multidisciplinary Home-Based Medication Review Program On Hospital Admissions In Older Adult Singaporeans

    Nov 1, 2014, 00:00

  • Health Economic Model for Novel in Vitro Diagnostic Kit for Infective Endocarditis

    Nov 1, 2014, 00:00

  • Treatment Patterns And Outcomes Of Patients Diagnosed With Ovarian Cancer In The Netherlands- A Registry Study

    Nov 1, 2014, 00:00

  • Is Canagliflozin Cost-Effective Compared to Sitagliptin Across Multiple Lines of Type 2 Diabetes Mellitus (T2dm) Therapy In Ireland?

    Nov 1, 2014, 00:00

  • Clinical and Cost-Effectiveness and Budget Impact of Routine Use of Bispectral Index Monitors In Theatres

    Nov 1, 2014, 00:00

  • Direct and Indirect Cost of HCV-Related Diseases in Italy- An Incidence-Based Probabilistic Approach

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of 10- and 13-Valent Pneumocococcal Conjugate Vaccines in the Philippines

    Nov 1, 2014, 00:00

  • Assessing the Economic Burden and Health Care Utilization of U. S. Medicare Patients Diagnosed with Melanoma

    Nov 1, 2014, 00:00

  • Orphan Drug Approvals In Europe- Historical Review and Trends

    Nov 1, 2014, 00:00

  • The Economic Cost Of Urinary Tract Infections In The Community- Results From Ireland

    Nov 1, 2014, 00:00

  • Cost of Treating Hip Fractures With Cephalomedullary Nails- A Retrospective Claims Database Review

    Nov 1, 2014, 00:00

  • Burden Of Disease Analysis Of Ankylosing Spondylitis In Hungary

    Nov 1, 2014, 00:00

  • Direct Costs of Treatment of Skin Drug Reactions Induced by Antibiotics in Perspective of Public Payer and Service Provider

    Nov 1, 2014, 00:00

  • Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

    Nov 1, 2014, 00:00

  • Effectiveness And Costs Of Different Strategies For The Diagnosis Of Stable Coronary Artery Disease Results From The Evinci Study

    Nov 1, 2014, 00:00

  • To What Extent Do Disease and Treatment Characteristics Influence Hta-Based Recommendations for A Sample of Orphan Drugs In Three Countries, and Could These Indicate Whether Orphan Drugs Have A “Special Status”?

    Nov 1, 2014, 00:00

  • The Dynamics Of Prices And Quantities Of New Drugs Under Taiwan's National Health Insurance Program

    Nov 1, 2014, 00:00

  • The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs- An Example of Slovenia

    Nov 1, 2014, 00:00

  • Current and Future Costs of Osteoporotic Fractures in the Netherlands

    Nov 1, 2014, 00:00

  • Treating to the Target of Das28 2.6 in Rheumatoid Arthritis- the Impact of Efficacy on Cost Effectiveness

    Nov 1, 2014, 00:00

  • Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

    Nov 1, 2014, 00:00

  • Subjective Expectations Regarding Life Expectancy And Health-Related Quality Of Life In Moderate To Severe Psoriasis Patients

    Nov 1, 2014, 00:00

  • Investigating the Framing-Effects of Risk Attributes in Discrete Choice Experiments- A Pilot Study

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa ...

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France

    Nov 1, 2014, 00:00

  • The Impact of Psychological Treatment of Rheumatic Patients With Mental Health

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain

    Nov 1, 2014, 00:00

  • Physicians As Double Agents In A Universal Health Care System- Evidence From Generic Pharmaceutical Adoption In Taiwan

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer – A Claims Data Analysis

    Nov 1, 2014, 00:00

  • A Retrospective, Longitudinal Study to Investigate the Change of LDL-C Level and Pharmaceutical Intervention by Using Japanese Health Care Checkup Database

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Asthma Management in a Hospital-Based Adult Asthma Clinic in Spain

    Nov 1, 2014, 00:00

  • Social Media Meets Population Health- A Sentiment And Demographic Analysis of Tobacco and E-Cigarette Use Across The “Twittersphere”

    Nov 1, 2014, 00:00

  • Efficacy, Effectiveness and the “Efficacy-To-Effectiveness Gap”- Review of the Current State of Play and Perspectives. First Results From the Imi Getreal Consortium

    Nov 1, 2014, 00:00

  • Budget Impact of Left Atrial Appendage Occulusion in Patients with Atrial Fibrillation Contraindicated to Anticoagulation

    Nov 1, 2014, 00:00

  • Accept® Questionnaire- Relation Between Acceptance And Compliance In Liver- And Kidney-Transplanted Patients Converted To Once-Daily Tacrolimus

    Nov 1, 2014, 00:00

  • Malnutrition in Institutionalized and Community-Dwelling Older Adults in Spain- Estimates of Its Costs To the National Health System

    Nov 1, 2014, 00:00

  • The Burden of Non-Small Cells Lung Cancer (NSCLC) in First Line (1L) Treatment- Patterns of Care and Cost of Illness

    Nov 1, 2014, 00:00

  • Clnical Management Of Non-Valvular Atrial Fibrillation In Hong Kong

    Nov 1, 2014, 00:00

  • Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension- Impact Of Age And Cardiovascular Risk Factors

    Nov 1, 2014, 00:00

  • Literature Review Of Pro Measures Assessing Anticoagulant Therapy

    Nov 1, 2014, 00:00

  • Comparison of Resource use and Health Care Costs in New Initiators of Long-Acting Injectable (Lai) and Oral Second Generation Antipsychotics

    Nov 1, 2014, 00:00

  • Pregnancy Outcomes in Women with Inflammatory Bowel Syndrome Following Exposure to Thiopurines and Anti-Tumor Necrosis Factor Drugs- A Meta-Analysis and Systematic Review

    Nov 1, 2014, 00:00

  • Metastatic Prostate Cancer and Skeletal Related Events, a Cost of Illness Study

    Nov 1, 2014, 00:00

  • Adverse Drug Events- How Information Technology will Meet the Challenges of Pharmacovigilance

    Nov 1, 2014, 00:00

  • Will Governments be Able to Afford a Cancer Cure Under Current Health Economic Evaluation Methods?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal

    Nov 1, 2014, 00:00

  • Efficacy of Ayurvedic Formulation in The Management of Essential Hypertension

    Nov 1, 2014, 00:00

  • Severity And Functional Disability Of Patients With Occupational Contact Dermatitis- Validation Of The German Version Of The Occupational Contact Dermatitis Disease Severity Index (ODDI)

    Nov 1, 2014, 00:00

  • Validation of The Hospital Episode Statistics Outpatient Dataset in England

    Nov 1, 2014, 00:00

  • General Beliefs About Medicines Among Depressed Patients in Saudi Arabia

    Nov 1, 2014, 00:00

  • Cerebrospinal Fluid ƒ"-Amyloid1-42 Levels in the Differential Diagnosis of Alzheimer's Disease - Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Current Status of Reimbursement Decisions for Orphan Drugs or Cancer Drugs and Implementation for Access Schemes in Korea

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

    Nov 1, 2014, 00:00

  • Impact of Copayment Reduction or Exemption Programme on Generic Drug Utilisation- the Specified Disease Treatment Research Programme in Japan

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Policy Updates in Asia

    Nov 1, 2014, 00:00

  • Drug Usage Analysis and Health Care Resources Consumption in Patients With Rheumatoid Arthritis

    Nov 1, 2014, 00:00

  • Hypertension Treatment in Chronic Kidney Disease Stage 3, 4 and 5- A Hospital Based Cross-Sectional Study in Malaysia

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis of EGFR-TK Mutation Status-Guided 1st- and 2nd-Line Treatment of Stage III/IV Non-Small Cell Lung Cancer in the UK

    Nov 1, 2014, 00:00

  • Evaluation of Selected Ken-Drgs in Greek Public Hospitals- The Degree to Which they Reflect Actual Expenditure and Average Length of Stay

    Nov 1, 2014, 00:00

  • Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

    Nov 1, 2014, 00:00

  • To Study the Treatment Pattern and Cost of Illness in Bipolar Disorder Patients in Tertiary Care Hospital in South India

    Nov 1, 2014, 00:00

  • Claims Reimbursement Analysis of the National Health Insurance Scheme in Ghana

    Nov 1, 2014, 00:00

  • Burden and Cost of Multiple Chronic Diseases in A Large Cohort of Elderly in Italy

    Nov 1, 2014, 00:00

  • The Presence of Anxiety Among Elementary Schools Obese Children

    Nov 1, 2014, 00:00

  • Bevacizumab for Metastatic Colorectal Cancer- A Literature Review on Meta-Analyses and Cost-Effectiveness Analyses

    Nov 1, 2014, 00:00

  • The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)

    Nov 1, 2014, 00:00

  • Impact of Omalizumab On All-Cause and Asthma-Related Health Care Resource Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • Making Sense of Nice's ‘New' MTA and STA Process Guide- A Narrative Synthesis

    Nov 1, 2014, 00:00

  • Cost Effectiveness Of Solifenacin Compared With Oral Antimuscarinic Agents For The Treatment Of Patients With Overactive Bladder (Oab) In The Uk

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of First-Line Regimen Between Cisplatin Plus Pemetrexed and Carboplatin Plus Paclitaxel In Advanced Non-Squamous Non-Small-Cell Lung Cancer in Thailand

    Nov 1, 2014, 00:00

  • Adherence, Predicting Factors and Satisfaction of Patients on Glaucoma Therapy- Findings From a Cross-Sectional Study in Korea

    Nov 1, 2014, 00:00

  • Impact of Influenza B in France

    Nov 1, 2014, 00:00

  • Using an Innovative Approach to Build a Prospective Diabetes Cohort Registry of Patients With Type 2 Diabetes in Germany- DIAREG

    Nov 1, 2014, 00:00

  • Patient Preferences in the Choice of Disease Modifying Anti-Rheumatic Drugs

    Nov 1, 2014, 00:00

  • Health Care Utilization and Cost Comparison Between Adherent Hypertension Patients Treated by Single Exforge HCT and Amlodipine/Valsartan/Hydrochlorothiazide Free Combination

    Nov 1, 2014, 00:00

  • Use of the Grace Checklist for Rating the Quality of Observational Comparative Effectiveness Research

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Portugal

    Nov 1, 2014, 00:00

  • Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany

    Nov 1, 2014, 00:00

  • Short-Term Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 2 Diabetes Mellitus in Spain

    Nov 1, 2014, 00:00

  • The Costs Of Atherosclerotic And Haemorrhagic Events Associated With Acute Coronary Syndrome (Acs) In Turkey

    Nov 1, 2014, 00:00

  • An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected Sepsisk

    Nov 1, 2014, 00:00

  • Use of Services and Cost of Agitation and Containment in Psychiatric Hospitals- a Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Use of Barricaid® In Lumbar Discectomy Surgery in Turkey

    Nov 1, 2014, 00:00

  • Economic Evaluation of Alzheimer

    Nov 1, 2014, 00:00

  • Orphan and Rare Diseases - the Payer Perspective

    Nov 1, 2014, 00:00

  • Costs of Psoriasis in Europe. A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS)

    Nov 1, 2014, 00:00

  • The Prevalence and Cost of Illness in Women With Endometriosis in Ukraine

    Nov 1, 2014, 00:00

  • Potential Cost-Effectiveness Of Therapeutic Drug Monitoring In Patients With Resistant Hypertension

    Nov 1, 2014, 00:00

  • Prospective Study on Quality of Life (QOL) of Bronchial Asthma Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Budget Impact on the Use of Pegfilgrastim to Reduce the Febrile Neutropenia During Chemotherapy for Breast Cancer with Moderate Risk Compared to a Standard Therapy

    Nov 1, 2014, 00:00

  • Comparing Characteristics of Hungarian “Real Life” Patients With Participants of RCTS- First-Line Disease Modifying Therapies in Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Forecasting Outpatient Pharmaceutical Expenditure for Cancer Treatment in Germany

    Nov 1, 2014, 00:00

  • Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer

    Nov 1, 2014, 00:00

  • Use of Hospital Services by HIV Patients, 2012

    Nov 1, 2014, 00:00

  • Market Access Pathway for Medical Nutrition in Europe and The Us

    Nov 1, 2014, 00:00

  • The Impact Of Drug Price Control Policy For Diabetes Medication- A Longitudinal Analysis In Taiwan

    Nov 1, 2014, 00:00

  • Archimedes- A Large Scale Simulation System for Health Care Research and its Applications for Asian Countries

    Nov 1, 2014, 00:00

  • Saudi Arabia- A very Attractive Biopharmaceutical Market, Once Manufacturers Can Navigate the Labyrinth

    Nov 1, 2014, 00:00

  • The Epidemiology of Medical Treatment for Glaucoma and Ocular Hypertension in Germany

    Nov 1, 2014, 00:00

  • Impact of Demographics on Health Preferences in China- An Exploratory Analysis of China EQ-5D-5L Valuation Study

    Nov 1, 2014, 00:00

  • Ldl-C Goal Attainment In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

    Nov 1, 2014, 00:00

  • Risk Factors Associated With Venous Thromboembolism Recurrence In A European Population

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biphasic Insulin Aspart In The Treatment Of Type 2 Diabetes Mellitus In Malaysia- A Public Payer Perspective

    Nov 1, 2014, 00:00

  • Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine Population

    Nov 1, 2014, 00:00

  • Literature Review of Decision-Analytical Models Used in the Economic Evaluation of Empirical/Targeted Antifungal Treatments for Invasive Fungal Infections

    Nov 1, 2014, 00:00

  • How Can the Quality of Life in Hand Eczema Questionnaire (qolheq) be Interpreted? A Banding Study

    Nov 1, 2014, 00:00

  • Health Technology Assessment and Environmental Costs- Time for Health Care To Catch Up?

    Nov 1, 2014, 00:00

  • Health Care Costs in Patients With Type 2 Diabetes in Flanders Based on A Combination of Clinical And Health Insurance Data

    Nov 1, 2014, 00:00

  • Economic Impact of New Rural Cooperative Medical Scheme In China

    Nov 1, 2014, 00:00

  • A Guideline-Based Estimate of Health Care Resource Use and Cost of Metastatic Unresectable Osteosarcoma

    Nov 1, 2014, 00:00

  • Discrete Event Simulation For The Cost-Effectiveness Evaluation Of Pet-Ct Scans In The Diagnosis Of Conn's Disease In Hypertensive Patients

    Nov 1, 2014, 00:00

  • Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests

    Nov 1, 2014, 00:00

  • Implementation of International Chart Review Studies- An Assessment of Ethics and Regulatory Considerations

    Nov 1, 2014, 00:00

  • Pricing and Reimbursement Environment For A Biologic Obtaining A Licence In A Second Indication in Key European Countries

    Nov 1, 2014, 00:00

  • Long-Term Modeling of Using Manually Coded and Autocoded Blood Glucose Meters in Diabetes Treatment

    Nov 1, 2014, 00:00

  • Analysis on Policies of Biosimilar Market in China

    Nov 1, 2014, 00:00

  • Impact of Omalizumab on Poor Asthma Control Events and Medication Utilisation in Patients With Moderate or Severe Persistent Asthma

    Nov 1, 2014, 00:00

  • Patient Characteristics and Medication Treatment Patterns Among Men With Erectile Dysfunction (Ed), Lower Urinary Tract Symptoms Secondary To Benign Prostatic Hyperplasia (Bph-Luts), Or Co-Occurring Ed and Bph-Luts In the Uk Primary Care Se ...

    Nov 1, 2014, 00:00

  • Pattern of Antidepressant Utilization and Cost in Iran From 2007-2011 in Comparison to European and East Asian Countries and Literature Review

    Nov 1, 2014, 00:00

  • Direct Health Care Costs Associated With Opioid-Induced Constipation

    Nov 1, 2014, 00:00

  • A Comparison of Market Access Evaluations for new Oncology Therapies in France, Germany and the UK- An Analysis Using the Prismaccess Database

    Nov 1, 2014, 00:00

  • The Value of Risk-Stratified Information in the National Lung Cancer Screening Trial

    Nov 1, 2014, 00:00

  • COUGH AS A KEY SYMPTOM IN ASTHMA, ALLERGIC RHINITIS, COPD AND RHINOSINUSITIS AND ITS IMPACT IN ASIA

    Nov 1, 2014, 00:00

  • Impact of Drug Policy Regulations on the Consumption of Antihypertensive Drugs in Slovakia

    Nov 1, 2014, 00:00

  • Cost Comparison of Surgical and Non-Surgical Treated Lumbar Spinal Stenosis Patients

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

    Nov 1, 2014, 00:00

  • Relationship Between the Direct Medical Costs and Direct Non-Medical Costs of Parkinson's Disease According to Disease Severity During 4 Years of Follow-Up in Spain

    Nov 1, 2014, 00:00

  • Validation of the SPHR Diabetes Prevention Model

    Nov 1, 2014, 00:00

  • Clinical Effectiveness of Fumaric Acid Esters (Fumaderm) in Psoriasis- A Systematic Review of Literature

    Nov 1, 2014, 00:00

  • Hospital Quality Of Infection Control

    Nov 1, 2014, 00:00

  • A Systematic Literature Review of the Humanistic Burden of Multiple Myeloma

    Nov 1, 2014, 00:00

  • Pharmacoepidemiology of Cellular/Tissue Derived Products for the Treatment of Venous Leg Ulcers in Outpatient Care Settings

    Nov 1, 2014, 00:00

  • Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

    Nov 1, 2014, 00:00

  • Rehabilitation In Resurfacing Hip Arthroplasty Patients- Preliminary Cost-Effectiveness Results From A Clinical Trial

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Analysis for Hiv Treatment Alternatives in Turkey

    Nov 1, 2014, 00:00

  • Potential Epidemics of Drugs Resistant Bacteria in Poverty Stricken Countries Like Pakistan

    Nov 1, 2014, 00:00

  • Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd)

    Nov 1, 2014, 00:00

  • Outcomes of Patients With Neovascular Age-Related Macular Degeneration (Namd) In Greece Under Ranibizumab

    Nov 1, 2014, 00:00

  • Reality in Market Access In Germany and France – Comparative Analysis of Added Benefit Decisions on Innovative Pharmaceutical Therapies

    Nov 1, 2014, 00:00

  • Strategies To Overcome Hurdles In Hta Appraisals Amid Limitations Resulting From Single-Arm Trial Data

    Nov 1, 2014, 00:00

  • The Burden of Myelofibrosis In Greece

    Nov 1, 2014, 00:00

  • Direct Costs of Diabetic Foot Ulcers in Russia

    Nov 1, 2014, 00:00

  • Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment

    Nov 1, 2014, 00:00

  • The Clinical Evidence Base of Treatment Options in Alzheimer's Disease- A Systematic Literature Search

    Nov 1, 2014, 00:00

  • Real-World Verse Randomised Controlled Trial Data- A Case Study On The Cost-Effectiveness Of Laparoscopic Surgery For Chronic Reflux

    Nov 1, 2014, 00:00

  • Estimating Costs in A Cost-Effectiveness Analysis- Adherence to HTA Guidance

    Nov 1, 2014, 00:00

  • Long-Term Trends in Breast Cancer Epidemiology in the Slovak Republic

    Nov 1, 2014, 00:00

  • Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals

    Nov 1, 2014, 00:00

  • Clinical Outcomes Associated with the Use of Guideline Recommended Care in Patients Post Discharge from Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2014, 00:00

  • Device Handling Errors and the Impact on Quality of Life and Health Care Resource Use in Asthmatic Patients

    Nov 1, 2014, 00:00

  • The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western Europe

    Nov 1, 2014, 00:00

  • Development Of An Influenza Outbreak Forecasting Model Using Time Series Analysis Methods

    Nov 1, 2014, 00:00

  • The Patient Voice in China- Status Quaestionis

    Nov 1, 2014, 00:00

  • Mabthera® (Rituximab) for the Treatment of Severe Granulomatosis With Polyangiitis (Gpa) and Microscopic Polyangiitis (Mpa) – A Cost-Utility Model for the United Kingdom

    Nov 1, 2014, 00:00

  • Upfront Overall Survival Modelling in Comparison to Real World Data- Lenalidomide for the Treatment of Multiple Myeloma Patients in South Korea

    Nov 1, 2014, 00:00

  • Assessing Willigness to Pay Among Psoriasis and Psoriatic Arthritis Patients

    Nov 1, 2014, 00:00

  • Factors Associated With Discontinuation of Sulfonylurea Therapy In Type 2 Diabetes Patients Who Initiate Insulin

    Nov 1, 2014, 00:00

  • The Study on the Prescribing Pattern of Acinetobacter Infection in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Hand Hygiene Compliance or the Influencing Factors of Efficiency in the Scope of Students

    Nov 1, 2014, 00:00

  • The Potential of (TARGETED) MR Colonography as a Screening Tool for Colorectal Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Annual Health Insurance Cost of Breast Cancer Treatment in Hungary

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in Dominican Republic, in Patients With Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

    Nov 1, 2014, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Cerebral Palsy and Other Paralytic Syndromes in Hungary

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Hepatitis a Vaccination in Indonesia

    Nov 1, 2014, 00:00

  • Dapagliflozin (Forxiga®) Versus Glipizide As Add-On Therapies In Type 2 Diabetes Mellitus (T2dm); An Update of The Cost-Effectiveness Based On Long-Term Clinical Evidence From Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Uncertainty and Probabilistic Methods in Multi-Criteria Decision Analysis

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95 (current)
  • 96
  • 97
  • 98
  • 99
  • 100
  • »